Case Study of Mucoepidermoid Carcinoma in the Middle Ear
Overview
Primary mucoepidermoid carcinoma (MEC) of the middle ear is an exceptionally rare malignancy. This case report details a 58-year-old woman presenting with purulent and bloody otorrhea, diagnosed with low-grade MEC, treated initially with mastoidectomy and radiotherapy, followed by extensive surgery upon recurrence, ultimately succumbing to disease two years later.
Background
Mucoepidermoid carcinoma is a malignancy typically arising in salivary glands but can rarely occur in other glandular-lined structures such as the middle ear. Middle ear MEC is extremely rare, with limited cases reported. Early symptoms often mimic chronic otitis media, delaying diagnosis. Histopathologically, MEC consists of mucous, epidermoid, and intermediate cells, and diagnosis relies on immunohistochemical profiling to differentiate it from other tumors.
Data Highlights
The patient initially presented with a 7-month history of purulent otorrhea progressing to bloody otorrhea and ipsilateral hearing loss. Imaging showed a soft tissue mass in the left mastoid, epitympanum, and mesotympanum without bone erosion. Histopathology confirmed low-grade MEC with no angiolymphatic or perineural invasion and low mitotic activity. Initial treatment included mastoidectomy and 3,000 cGy radiotherapy. Recurrence occurred 9 months later, necessitating subtotal temporal bone resection, partial parotidectomy, and neck dissection. Despite clear margins and no lymph node involvement, the patient died 2 years after the second surgery due to tumor recurrence.
Key Findings
Primary mucoepidermoid carcinoma of the middle ear is extremely rare and can present with symptoms mimicking chronic otitis media.
Diagnosis requires histopathological and immunohistochemical confirmation distinguishing MEC from other middle ear tumors.
Initial treatment with mastoidectomy and radiotherapy may be insufficient, as local recurrence can occur within months.
Comprehensive surgical resection including temporal bone resection and neck dissection may be necessary for recurrent disease.
Even with clear surgical margins and no lymph node involvement, prognosis remains poor with potential for fatal recurrence.
Clinical vigilance for bloody otorrhea and persistent symptoms is critical for early diagnosis and management.
Clinical Implications
Clinicians should maintain a high index of suspicion for malignancy in patients with persistent or bloody otorrhea and hearing loss, as early symptoms of middle ear MEC mimic benign conditions. Definitive diagnosis requires biopsy and immunohistochemical analysis. Treatment often necessitates aggressive surgical management combined with radiotherapy, but recurrence risk remains high, underscoring the need for close follow-up and consideration of adjuvant therapies.
Conclusion
Mucoepidermoid carcinoma of the middle ear is a rare but aggressive malignancy with nonspecific early symptoms leading to diagnostic delays. Comprehensive surgical and adjuvant treatments are essential, yet prognosis remains guarded due to high recurrence rates.
References
Stewart and Becker 1945 -- Initial characterization of mucoepidermoid carcinoma
Case report and literature review -- Primary mucoepidermoid carcinoma of the middle ear
Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.
